{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:09:29Z","timestamp":1790766569332,"version":"4.1.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T00:00:00Z","timestamp":1440028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005084","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T13:59:28Z","timestamp":1440079168000},"page":"e1005084","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control"],"prefix":"10.1371","volume":"11","author":[{"given":"Karoly","family":"Toth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoling","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline F.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Tollefson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Sagartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Keun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongde","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S. M.","family":"Wold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,20]]},"reference":[{"key":"ref1","first-page":"1704","article-title":"Fields Virology","author":"AJ Berk","year":"2013"},{"issue":"Pt 1","key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"WC Russell","year":"2009","journal-title":"J Gen Virol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"T Lion","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1086\/648591","article-title":"Comparative cell-mediated immunogenicity of DNA\/DNA, DNA\/adenovirus type 5 (Ad5), or Ad5\/Ad5 HIV-1 clade B gag vaccine prime-boost regimens","volume":"201","author":"DM Asmuth","year":"2010","journal-title":"J Infect Dis"},{"key":"ref5","first-page":"1732","article-title":"Fields Virology","author":"WSM Wold","year":"2013"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1586\/14787210.2013.836964","article-title":"Diagnosis and treatment of adenovirus infection in immunocompromised patients","volume":"11","author":"S Matthes-Martin","year":"2013","journal-title":"Expert review of anti-infective therapy"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11908-014-0416-y","article-title":"Adenovirus: current epidemiology and emerging approaches to prevention and treatment","volume":"16","author":"U Sandkovsky","year":"2014","journal-title":"Current infectious disease reports"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/hum.2014.001","article-title":"Innate immunity to adenovirus","volume":"25","author":"R Hendrickx","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"11","key":"ref9","first-page":"e1000208","article-title":"Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo","volume":"4","author":"G Fejer","year":"2008","journal-title":"PLoSPathog"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/JVI.02685-06","article-title":"Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator","volume":"81","author":"M Nociari","year":"2007","journal-title":"J Virol"},{"issue":"24","key":"ref11","doi-asserted-by":"crossref","first-page":"14426","DOI":"10.1128\/JVI.02608-14","article-title":"Unabated adenovirus replication following activation of the cGAS\/STING-dependent antiviral response in human cells","volume":"88","author":"E Lam","year":"2014","journal-title":"J Virol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1128\/JVI.02702-13","article-title":"Adenovirus detection by the cGAS\/STING\/TBK1 DNA sensing cascade","volume":"88","author":"E Lam","year":"2014","journal-title":"J Virol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.immuni.2010.03.012","article-title":"Intracellular toll-like receptors","volume":"32","author":"AL Blasius","year":"2010","journal-title":"Immunity"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.4049\/jimmunol.1103717","article-title":"Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity","volume":"188","author":"MJ Johnson","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.vaccine.2013.11.055","article-title":"Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression","volume":"32","author":"MJ Johnson","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"ref16","first-page":"614","article-title":"Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters","volume":"17","author":"S Bortolanza","year":"2009","journal-title":"MolTher"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-12-398342-8.00008-2","article-title":"Chapter eight\u2014Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans","volume":"115","author":"V Cerullo","year":"2012","journal-title":"Adv Cancer Res"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/mt.2009.156","article-title":"Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model","volume":"17","author":"D Dhar","year":"2009","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/cgt.2008.80","article-title":"Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats","volume":"16","author":"AM Sonabend","year":"2009","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/cgt.2009.36","article-title":"New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster","volume":"16","author":"JF Spencer","year":"2009","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-05-3497","article-title":"Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors","volume":"66","author":"MA Thomas","year":"2006","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/mt.2008.162","article-title":"Immunosuppression enhances oncolytic adenovirus replication and anti tumor efficacy in the Syrian hamster model","volume":"16","author":"MA Thomas","year":"2008","journal-title":"Mol Ther"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/JVI.02127-08","article-title":"Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters","volume":"83","author":"D Dhar","year":"2009","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-61779-340-0_4","article-title":"Syrian hamster tumor model to study oncolytic Ad5-based vectors","volume":"797","author":"D Dhar","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cgt.2014.13","article-title":"Cycles of transient high-dose cyclophosphamide administration and intratumoral oncolytic adenovirus vector injection for long-term tumor suppression in Syrian hamsters","volume":"21","author":"D Dhar","year":"2014","journal-title":"Cancer Gene Ther"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/cgt.2013.49","article-title":"The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors","volume":"20","author":"BA Young","year":"2013","journal-title":"Cancer Gene Ther"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/cgt.2013.50","article-title":"The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model","volume":"20","author":"BA Young","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/cgt.2009.5","article-title":"An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector","volume":"16","author":"DL Lichtenstein","year":"2009","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/cgt.2009.6","article-title":"INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies","volume":"16","author":"B Ying","year":"2009","journal-title":"Cancer Gene Ther"},{"issue":"20","key":"ref30","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0800200105","article-title":"Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model","volume":"105","author":"K Toth","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2014.10.005","article-title":"Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model","volume":"112","author":"AE Tollefson","year":"2014","journal-title":"Antiviral Res"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3390\/v7031409","article-title":"Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters","volume":"7","author":"K Toth","year":"2015","journal-title":"Viruses"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1128\/AAC.03860-14","article-title":"Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters","volume":"58","author":"B Ying","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"e109755","DOI":"10.1371\/journal.pone.0109755","article-title":"Efficient gene targeting in golden Syrian hamsters by the CRISPR\/Cas9 system","volume":"9","author":"Z Fan","year":"2014","journal-title":"PloS one"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"e27521","DOI":"10.4161\/jkst.27521","article-title":"STAT2 and IRF9: Beyond ISGF3","volume":"2","author":"K Fink","year":"2013","journal-title":"Jak-Stat"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"e27080","DOI":"10.4161\/jkst.27080","article-title":"STATs get their move on","volume":"2","author":"NC Reich","year":"2013","journal-title":"Jak-Stat"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1074-7613(00)00077-7","article-title":"Immune response in Stat2 knockout mice","volume":"13","author":"C Park","year":"2000","journal-title":"Immunity"},{"issue":"20","key":"ref38","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0800200105","article-title":"Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model","volume":"105","author":"K Toth","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0092-8674(86)90383-1","article-title":"Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase","volume":"45","author":"J Kitajewski","year":"1986","journal-title":"Cell"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0092-8674(82)90310-5","article-title":"Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection","volume":"31","author":"B Thimmappaya","year":"1982","journal-title":"Cell"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.30.1.52","article-title":"Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters","volume":"30","author":"EN Fish","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"JM Gonzalez-Navajas","year":"2012","journal-title":"Nature reviews Immunology"},{"key":"ref43","first-page":"7","article-title":"Innate immune responses to LCMV infections: natural killer cells and cytokines","volume":"263","author":"CA Biron","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1556\/EuJMI.1.2011.4.3","article-title":"Adenovirus-triggered innate signalling pathways","volume":"1","author":"G Fejer","year":"2011","journal-title":"European journal of microbiology & immunology"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/hum.2004.15.1157","article-title":"The Innate Immune Response to Adenovirus Vectors","volume":"15","author":"DA Muruve","year":"2004","journal-title":"Hum Gene Ther"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4049\/jimmunol.156.3.1055","article-title":"Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding","volume":"156","author":"JM Routes","year":"1996","journal-title":"J Immunol"},{"issue":"16","key":"ref47","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1093\/nar\/19.16.4387","article-title":"Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene","volume":"19","author":"AM Ackrill","year":"1991","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"ref48","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1073\/pnas.88.18.7913","article-title":"Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene","volume":"88","author":"MJ Gutch","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"ref49","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1073\/pnas.88.17.7459","article-title":"Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation","volume":"88","author":"DV Kalvakolanu","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.chom.2012.05.005","article-title":"Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification","volume":"11","author":"GJ Fonseca","year":"2012","journal-title":"Cell host & microbe"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1128\/JVI.61.3.787-795.1987","article-title":"Adenovirus early region 1A modulation of interferon antiviral activity","volume":"61","author":"KP Anderson","year":"1987","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4049\/jimmunol.156.3.1055","article-title":"Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding","volume":"156","author":"JM Routes","year":"1996","journal-title":"JImmunol"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1074-7613(00)80652-4","article-title":"Direct suppression of Stat1 function during adenoviral infection","volume":"9","author":"DC Look","year":"1998","journal-title":"Immunity"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1165\/rcmb.2007-0158OC","article-title":"Inhibition of Jak1-dependent signal transduction in airway epithelial cells infected with adenovirus","volume":"37","author":"L Shi","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/JVI.03387-12","article-title":"The repression domain of the E1B 55-kilodalton protein participates in countering interferon-induced inhibition of adenovirus replication","volume":"87","author":"JS Chahal","year":"2013","journal-title":"J Virol"},{"issue":"8","key":"ref56","doi-asserted-by":"crossref","first-page":"e1002853","DOI":"10.1371\/journal.ppat.1002853","article-title":"The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells","volume":"8","author":"JS Chahal","year":"2012","journal-title":"PLoS Pathog"},{"issue":"15","key":"ref57","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.1128\/JVI.00723-08","article-title":"Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein","volume":"82","author":"AJ Ullman","year":"2008","journal-title":"J Virol"},{"issue":"9","key":"ref58","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/JVI.02385-06","article-title":"Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response","volume":"81","author":"AJ Ullman","year":"2007","journal-title":"J Virol"},{"issue":"11","key":"ref59","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1128\/JVI.00469-14","article-title":"Sp100 isoform-specific regulation of human adenovirus 5 gene expression","volume":"88","author":"J Berscheminski","year":"2014","journal-title":"J Virol"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.4049\/jimmunol.178.6.3505","article-title":"Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus","volume":"178","author":"J Zhu","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1006\/mthe.2001.0330","article-title":"Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors","volume":"3","author":"MA Schnell","year":"2001","journal-title":"Mol Ther"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.gt.3302347","article-title":"Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice","volume":"12","author":"AN Varnavski","year":"2005","journal-title":"Gene Ther"},{"issue":"6","key":"ref63","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.mt.6300162","article-title":"Prostate cancer gene therapy clinical trials","volume":"15","author":"SO Freytag","year":"2007","journal-title":"Mol Ther"},{"issue":"3","key":"ref64","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.4049\/jimmunol.175.3.1820","article-title":"Depletion of T cells by type I interferon: differences between young and aged mice","volume":"175","author":"J Jiang","year":"2005","journal-title":"J Immunol"},{"issue":"10","key":"ref65","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2006-06-027599","article-title":"Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia","volume":"108","author":"E Kamphuis","year":"2006","journal-title":"Blood"},{"issue":"23","key":"ref66","first-page":"1748","article-title":"Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment","volume":"45","author":"F Toccaceli","year":"1998","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/jir.1986.6.507","article-title":"Effects of interferon on the lymphocyte subset in the blood and lymphoid organs in mice","volume":"6","author":"H Kawasaki","year":"1986","journal-title":"J Interferon Res"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0092-8674(79)90275-7","article-title":"Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells","volume":"17","author":"N Jones","year":"1979","journal-title":"Cell"},{"issue":"1","key":"ref69","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(84)90325-8","article-title":"Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cells","volume":"37","author":"RJ Schneider","year":"1984","journal-title":"Cell"},{"issue":"1","key":"ref70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1008190504521","article-title":"The hamster polyomavirus\u2014a brief review of recent knowledge","volume":"22","author":"S Scherneck","year":"2001","journal-title":"Virus Genes"},{"issue":"1\u20132","key":"ref71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jim.2011.02.004","article-title":"Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus)","volume":"368","author":"M Zivcec","year":"2011","journal-title":"J Immunol Methods"},{"issue":"4","key":"ref72","first-page":"271","article-title":"Isolation of lymphocytes and their innate immune characterizations from liver, intestine, lung and uterus","volume":"2","author":"J Zhang","year":"2005","journal-title":"Cellular & molecular immunology"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1005392","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T04:54:51Z","timestamp":1691902491000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005084"}},"subtitle":[],"editor":[{"given":"Roger D","family":"Everett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,20]]},"references-count":72,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005084","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,20]]}}}